Profusa, Inc. Common Stock(PFSA)

Medical - Devices · Berkeley, CA

$1.66-0.09 (-5.14%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T22:42:49.283Z.

Stored calculation inputs

Calculation as of: 2026-10-06T22:42:49.283Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 1,830,261
Total debt · period ending 2026-06-30: 14,004,000
Cash · period ending 2026-06-30: 719,000
TTM free cash flow · period ending 2026-06-30: -21,032,390

FMP input reference: f8447282adf6e47d1ec21ed7020f0f216562717f012d53baf90ed137265b4b00

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

PFSA EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

PFSA Competitors' EV/FCF Ratio

PFSA

Profusa, Inc. Common Stock

Current

Market Cap

$1.83M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

XAIR

Beyond Air, Inc.

vs PFSA

Market Cap

$1.84M

EV/FCF Ratio

N/A

TTM Avg

72.16x

3Y Avg

72.16x

5Y Avg

72.16x

TNON

Tenon Medical, Inc.

vs PFSA

Market Cap

$1.84M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TCRT

Alaunos Therapeutics, Inc.

vs PFSA

Market Cap

$1.81M

EV/FCF Ratio

N/A

TTM Avg

69.66x

3Y Avg

69.66x

5Y Avg

69.66x

RNAZ

TransCode Therapeutics, Inc.

vs PFSA

Market Cap

$1.88M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AMIX

Autonomix Medical, Inc.

vs PFSA

Market Cap

$1.88M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SILO

Silo Pharma, Inc.

vs PFSA

Market Cap

$1.64M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GOVX

GeoVax Labs, Inc.

vs PFSA

Market Cap

$2.13M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

VVOS

Vivos Therapeutics, Inc.

vs PFSA

Market Cap

$2.14M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LABT

Lakewood-Amedex Biotherapeutics, Inc.

vs PFSA

Market Cap

$1.52M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Profusa, Inc. Common Stock (PFSA)	$1.83M	N/A	N/A	N/A	N/A
Beyond Air, Inc. (XAIR)vs ›	$1.84M	N/A	72.16x	72.16x	72.16x
Tenon Medical, Inc. (TNON)vs ›	$1.84M	N/A	N/A	N/A	N/A
Alaunos Therapeutics, Inc. (TCRT)vs ›	$1.81M	N/A	69.66x	69.66x	69.66x
TransCode Therapeutics, Inc. (RNAZ)vs ›	$1.88M	N/A	N/A	N/A	N/A
Autonomix Medical, Inc. (AMIX)vs ›	$1.88M	N/A	N/A	N/A	N/A
Silo Pharma, Inc. (SILO)vs ›	$1.64M	N/A	N/A	N/A	N/A
GeoVax Labs, Inc. (GOVX)vs ›	$2.13M	N/A	N/A	N/A	N/A
Vivos Therapeutics, Inc. (VVOS)vs ›	$2.14M	N/A	N/A	N/A	N/A
Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs ›	$1.52M	N/A	N/A	N/A	N/A

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio: N/A

PFSA EV/FCF Ratio Metrics

PFSA Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

Related Metrics